Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CP-724,714 + XMU-MP-2 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CP-724,714 | CP 724714|CP-724714 | HER2 Inhibitor 44 | CP-724,714 is a selective inhibitor of ERBB2 (HER2), which reduces ERBB2 signaling and may decrease growth of ERBB2 (HER2)-over expressing tumors (PMID: 17942920). | |
| XMU-MP-2 | XMU-MP-2 is a small molecule that inhibits PTK6 (BRK), resulting in decreased downstream signaling and reduced proliferation of PTK6 (BRK)-expressing tumor cells (PMID: 27758886). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|